Stephan Toutain

Stephan Toutain is the Senior Vice President of Operations at Anavex Life Sciences. Stephan has over 20 years of experience in the biotechnology and pharmaceutical industry. Stephan has held various leadership positions at multinational companies, including Johnson & Johnson, Alexion Pharmaceuticals, Celgene Corp., and Sarepta Therapeutics. In their current role, Stephan is responsible for the development and implementation of the commercial strategy for Anavex Life Sciences.

Stephan Toutain has a Master of Business Administration from the University of North Carolina at Chapel Hill - Kenan-Flagler Business School, an Executive Program in Sales & International Business from the Business Institut of Lyon, and a Master of Science in Biotechnology from the University of Nancy.

Some of their coworkers include Walter E Kaufmann - Chief Medical Officer, Daniel Klamer - Vice President of Business Development and Scientific Strategy, and Emmanuel O Fadiran - Senior Vice President of Regulatory Affairs . Stephan Toutain reports to Christopher Missling, President & CEO.